Menu
Washingtoner
  • Home
  • Health
  • Business
  • Books
  • Lifestyle
  • Aerospace
  • Technology
  • Artificial Intelligence
  • Legal
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Spokane: Chat & Chew District 3 Council Members
  • Haven Media Solutions Offers Web Design and PPC Services in Atlanta GA
  • Spokane: Council Members Introduce An Ordinance Imposing Data Center Moratorium
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Tacoma: A Statement from At-Large Council Member Latasha Palmer on Rental Housing Resolution
  • Tacoma City Council Adopts Six-Year Transportation Improvement Program
  • Tacoma City Council Adopts 2026 Annual Code Amendments
  • What Happens When Congress Says No? New Book Examines the Boland Amendments, Iran-Contra Affair & Jamaican Posse, as US Congress Debate Over Military
  • Beware of Fake City of Spokane Development and Permit Invoices

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Inframark–Slater Joint Venture Selected to Manage Fulton County Wastewater Operations
  • Cancun International Airport Reports Strong Start to Summer 2026 Travel Season
  • Freedomtech Solutions Launches the World's First Pre‑Installed Agentic AI Server — Instant, Sovereign, Infrastructure‑Native Intelligence
  • GitKraken Introduces Code Flow, a Framework for Software Development in the Agentic Era
  • SanctionsLookup Launches Free OFAC Search Tool for U.S. Sanctions Screening
  • RIGHT CARS Announces Landmark African Expansion Through Strategic Collaboration Agreement Across Eight Nations
  • Spokane: Housing and Human Services Dept. Provides Update on Housing and Homelessness Initiatives
  • Boston Industrial Solutions' Natron® 717N Series UV LED Ink Receives CPSIA Certification
  • Spokane City Clerk To Retire After 30 Years In Role, Successor Named
  • purelyIV Expands Mobile IV Therapy to Jackson, MI and Launches PlaqueX® IV Therapy
  • Leimert Juneteenth Community Celebration Set for Friday, June 19, in Leimert Park Village
  • UK Financial Ltd Publishes Maya Preferred Public Proof Package and CoinMarketCap Supply Verification Evidence
  • Haven Treatment Center Launches Community Haircut Drive to Help Local Families
  • Advancing High-Potential Nevada Critical Minerals Portfolio as Major Drill Program Nears Assay Results: Glenstar Minerals: Stock Symbol: GSTRF
  • Allstream Energy Partners to Host 6th Executive Networking After 2026 Energy Projects Conference
  • CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
  • Custom Disposables - Wholesale Packaging Solutions for restaurants, food chains, and food distributors
  • California Security Glass is an affordable bulletproof glass installation company in LA serving a variety of neighboring cities
  • Allstream Energy Partners Announce Media Partnership with the 2026 EPC Show - The Energy Projects Conference
  • STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
_catLbl0 _catLbl1

Popular on Washingtoner

  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan - 300
  • Kevin Francis Design Introduces CHROMA, a Collection of Saturated Solid Color Wool Rugs
  • Joseph Nybyk aka Neibich of Gilbert, Arizona
  • Spokane: Coffee Connect With District 1 Council Members
  • AI Predicts the Most Likely 2026 FIFA World Cup Winner
  • Curious About Mensa? DFW Event Offers a 1-Day Immersion
  • Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
  • City of Tacoma Observes Memorial Day on May 25
  • Children's Author Releases Second Inspiring Career Book
  • Spokane: SPD is Seeking Public's Assistance in Locating Dangerous Offender

Similar on Washingtoner

  • Compton to host first Juneteenth celebration with We Are Us Festival
  • Qscription Technologies Appoints Anurag Velekkatt Sunil Kumar to Drive Enterprise Scale
  • A New Pulse for Cardiac Care in Baltimore: St. Elizabeth Rehab & Nursing Welcomes Dr. Hakim Uqdah and Expands Advanced Heart Program
  • Boston Industrial Solutions' Natron® 717N Series UV LED Ink Receives CPSIA Certification
  • purelyIV Expands Mobile IV Therapy to Jackson, MI and Launches PlaqueX® IV Therapy
  • Haven Treatment Center Launches Community Haircut Drive to Help Local Families
  • CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
  • CCHR Condemns Behavioral Treatment After FDA's Missed Deadline to Ban Shock Device
  • Keynote Speaker announced for the 2026 NCIHC Language Access Congress
  • Expanding Access to Mental Health Care in Toronto with Dr. Stephen Shainbart
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute